GSK

GSK is a leading global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. ​They prevent and treat disease with specialty medicines, vaccines and general medicines.

GSK has donated over £314,000 to Meningitis Now awareness and support projects over 20 years. This includes the delivery of our MARM initiative to increase people’s knowledge of meningitis in healthcare and educational settings, the delivery of more than 1 million of our life-saving meningitis signs and symptoms cards within community groups across the UK and funding to support more than 100 young people through our Believe & Achieve Programme.

In 2024, GSK generously supported a new meningitis awareness campaign for 14–18-year-olds at secondary schools and sixth form colleges across the UK. Thanks to a GSK grant, we have created a video that features Eliana Shaw-Lothian describing her traumatic meningitis experience whilst at university in 2023. The film is now being shown in sixth form colleges and secondary schools across the UK, and also features Eliana’s housemates and a medical professional.

Read more about the video.

In 2025, GSK supported our Stories of Hope photography exhibition, which has toured around the UK. The exhibition showcased powerful personal stories from people affected by meningitis, highlighting both the devastating impact of the disease and the resilience, strength and hope shown by those living with its consequences. Through storytelling, the exhibition has helped to raise awareness of meningitis while offering hope for a future where no one loses their life to the disease, and everyone affected receives the support they need to rebuild their lives. Find out more.

GSK’s support continues in 2026, with a grant to support our Student Awareness campaign to help us reach more young people and parents than ever before with vital signs and symptoms information, with the goal of saving lives.

Visit GSK online.